Relapsing MOG Ab demyelination syndromes are considered distinct from multiple sclerosis (MS) based on clinical and neuroimaging features, and MOG antibody seropositivity is associated with a non-MS course at 1-year follow-up [11, 12]. This evidence concerns the gene MOG and myeloid sarcoma.